Identification of a Pro-Angiogenic Potential and Cellular Uptake Mechanism of a LMW Highly Sulfated Fraction of Fucoidan from Ascophyllum nodosum
暂无分享,去创建一个
Murielle Maire | Nadia Djaker | A. Sutton | N. Charnaux | O. Oudar | H. Hlawaty | F. Chaubet | N. Marinval | Nathalie Charnaux | M. Lamy de la Chapelle | Angela Sutton | Olivier Oudar | C. Laguillier-Morizot | C. Chauvierre | Oualid Haddad | Hanna Hlawaty | Pierre Saboural | Marc Lamy de la Chapelle | Frederic Chaubet | N. Djaker | O. Haddad | Cedric Chauvierre | Nicolas Marinval | Kevin Bassand | Frederic Geinguenaud | Khadija Ben Akrout | Romain Robert | Erwan Guyot | Christelle Laguillier-Morizot | F. Geinguenaud | M. Maire | Pierre Saboural | Erwan Guyot | K. Bassand | Khadija Ben Akrout | R. Robert | Murielle Maire
[1] Loïc Martin,et al. Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells , 2007, Molecular Cancer Therapeutics.
[2] Jung-Hwan Yoon,et al. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[3] Paulo J. A. Ribeiro-Claro,et al. Identification of selected seaweed polysaccharides (phycocolloids) by vibrational spectroscopy (FTIR-ATR and FT-Raman) , 2009 .
[4] Rongying Zhang,et al. The effect of the size of fluorescent dextran on its endocytic pathway , 2015, Cell biology international.
[5] Didier Letourneur,et al. Low Molecular Weight Fucoidan Increases VEGF165-induced Endothelial Cell Migration by Enhancing VEGF165 Binding to VEGFR-2 and NRP1* , 2006, Journal of Biological Chemistry.
[6] Beom-Su Kim,et al. Fucoidan/FGF-2 induces angiogenesis through JNK- and p38-mediated activation of AKT/MMP-2 signalling. , 2014, Biochemical and biophysical research communications.
[7] P. Hwang,et al. Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia , 2015, Marine drugs.
[8] J. Michel,et al. Low-Molecular-Weight Fucoidan Promotes Therapeutic Revascularization in a Rat Model of Critical Hindlimb Ischemia , 2003, Journal of Pharmacology and Experimental Therapeutics.
[9] A. Amarasekara,et al. Effect of oversulfation on the chemical and biological properties of fucoidan , 2006 .
[10] D. Le Guludec,et al. Purification of a Low Molecular Weight Fucoidan for SPECT Molecular Imaging of Myocardial Infarction , 2014, Marine drugs.
[11] A. Duchesnay,et al. Synthesis and biological activities of a library of glycosaminoglycans mimetic oligosaccharides. , 2011, Biomaterials.
[12] E. Tkachenko,et al. Syndecans: new kids on the signaling block. , 2005, Circulation research.
[13] F. Chaubet,et al. Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets. , 2009, Biochimica et biophysica acta.
[14] U. Welsch,et al. GLYCOCALYX PROTECTION REDUCES LEUKOCYTE ADHESION AFTER ISCHEMIA/REPERFUSION , 2010, Shock.
[15] R. Williams,et al. A revised structure for fucoidan may explain some of its biological activities. , 1993, The Journal of biological chemistry.
[16] Structural Features and Anti-coagulant Activity of the Sulphated Polysaccharide SPS-CF from a Green Alga Capsosiphon fulvescens , 2015, Marine Biotechnology.
[17] Shingo Nakamura,et al. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization. , 2008, Journal of biomedical materials research. Part A.
[18] P. Albanese,et al. A fine structural modification of glycosaminoglycans is correlated with the progression of muscle regeneration after ischaemia: towards a matrix-based therapy? , 2015, European cells & materials.
[19] Menger,et al. The polysaccharide fucoidan inhibits microvascular thrombus formation independently from P‐ and l‐selectin function in vivo , 2000, European journal of clinical investigation.
[20] M. Bilan,et al. Structure of a fucoidan from the brown seaweed Fucus evanescens C.Ag. , 2002, Carbohydrate research.
[21] V. Pomin. Fucanomics and galactanomics: current status in drug discovery, mechanisms of action and role of the well-defined structures. , 2012, Biochimica et biophysica acta.
[22] Diego Mantovani,et al. Fucoidan in a 3D scaffold interacts with vascular endothelial growth factor and promotes neovascularization in mice , 2013, Drug Delivery and Translational Research.
[23] Rangeetha J Naik,et al. Exogenous chondroitin sulfate glycosaminoglycan associate with arginine-rich peptide-DNA complexes to alter their intracellular processing and gene delivery efficiency. , 2015, Biochimica et biophysica acta.
[24] G. Garcı́a-Cardeña,et al. Hemodynamic shear stress characteristic of atherosclerosis-resistant regions promotes glycocalyx formation in cultured endothelial cells. , 2013, American journal of physiology. Cell physiology.
[25] A. Sutton,et al. Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells. , 2009, Glycobiology.
[26] Xiang-yang Zou,et al. Fucoidan Suppresses Hypoxia-Induced Lymphangiogenesis and Lymphatic Metastasis in Mouse Hepatocarcinoma , 2015, Marine drugs.
[27] A. Sutton,et al. Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis , 2015, Marine drugs.
[28] M. Bilan,et al. Fucoidans: pro- or antiangiogenic agents? , 2014, Glycobiology.
[29] S. Matou,et al. Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro. , 2002, Thrombosis research.
[30] O. Berteau,et al. Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. , 2003, Glycobiology.
[31] J. Turnbull,et al. A synthetic glycosaminoglycan mimetic (RGTA) modifies natural glycosaminoglycan species during myogenesis , 2005, Journal of Cell Science.
[32] G. Caligiuri,et al. Neoangiogenesis induced by progenitor endothelial cells: effect of fucoidan from marine algae. , 2007, Cardiovascular & hematological agents in medicinal chemistry.
[33] J. Deux,et al. Low Molecular Weight Fucoidan Prevents Neointimal Hyperplasia in Rabbit Iliac Artery In-Stent Restenosis Model , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[34] M. Bilan,et al. Influence of Fucoidans on Hemostatic System , 2013, Marine drugs.
[35] Maeve Kelly,et al. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. , 2007, Glycobiology.
[36] Sylvie Ricard-Blum,et al. Heparin-protein interactions: from affinity and kinetics to biological roles. Application to an interaction network regulating angiogenesis. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[37] Soraya Fermas,et al. Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis. , 2008, Glycobiology.
[38] A. Sutton,et al. Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression. , 2011, Biochemical pharmacology.
[39] B. Caleb,et al. Binding and internalization of heparin by vascular smooth muscle cells , 1985, Journal of cellular physiology.
[40] P. Legrand,et al. A spectroscopic investigation of the carrageenans and agar in the 1500-100 cm−1 spectral range , 1993 .